Pertussis toxin protein (ab63830)
Constituents: 0.0268% PBS, 10% Glycerol, 0.8% Sodium chloride
Our Abpromise guarantee covers the use of ab63830 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|SDS-PAGE||SDS-PAGE: Use at an assay dependent dilution.|
|Functional Studies||FuncS: Use at an assay dependent dilution. Cytotoxicity of the Pertussis Toxin was confirmed by morphological alteration of CHO cells after treatment with 0.1 ng/ml of the Pertussis Toxin.|
- IAP S1IAP S2IAP S3
- IAP S4IAP S5Islet activating protein S1Islet activating protein S2Islet activating protein S3Islet activating protein S4Islet activating protein S5NAD dependent ADP ribosyltransferasePertussis toxin subunit 1Pertussis toxin subunit 2Pertussis toxin subunit 3Pertussis toxin subunit 4Pertussis toxin subunit 5PTX S1PTX S2PTX S3PTX S4PTX S5PtxAPtxBPtxCPtxDPtxE
Pertussis toxin protein images
ab63830 on SDS-PAGE.
Left Panel: Control CHO cell culture without Pertussis Toxin. Right Panel: CHO cells treated with Pertussis Toxin at 0.1 ng/ml in the culture medium for 17 hr at 37oC.
References for Pertussis toxin protein (ab63830)
ab63830 has not yet been referenced specifically in any publications.